Back to search results

Opioid Package Prototype (OPP) for Post-Surgery Pain

This study is looking at a new type of packaging for oxycodone, a pain medication, called the Opioid Package Prototype (OPP). This new package is child-resistant and senior-friendly, with a calendar-blister design and space for clear labeling. Researchers want to see if this new packaging helps doctors prescribe, pharmacies dispense, and patients use oxycodone more safely and effectively after orthopedic surgery. You might be able to join if you are 18 or older, having orthopedic surgery that requires oxycodone for pain, and are willing to receive oxycodone. The study will measure how many oxycodone tablets are prescribed at 1 week, 1 month, and 3 months after surgery. The current status of this study is unclear.

Study design
This interventional study plans to enroll 352 participants. It compares the Opioid Package Prototype (OPP) to standard amber vials for dispensing oxycodone.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will measure the number of oxycodone tablets prescribed at 1 week, 1 month, and 3 months after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04598074

Opioid Package Prototype (OPP)

Not Yet Recruiting
NAAges 18+InterventionalHealth services
UConn Health
~352 participants
Updated 2025-09-05 on ClinicalTrials.gov
What's tested:Opioid Package Prototype (OPP)Usual Care (standard amber vial)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of tablets of oxycodone prescribed
Measured over 1 week after surgery
+11 more outcomes measured

Conditions

Opioid Use
Opioid Prescribing, Dispensing, and Patient Use

Explore related trials

Orthopedic Rehabilitation SurgeryPost-Operative Pain

Where it's being run

1 sites across 1 states
Connecticut1

Study leadership

  • Nathaniel M Rickles, PharmD, PhD, BCPP, FAPhA · PRINCIPAL_INVESTIGATOR · University of Connecticut

Who to contact

Nathaniel M Rickles, PharmD, PhD, BCPP, FAPhA
[email protected]
860-486-6026
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

What this trial measures

  • Number of tablets of oxycodone prescribed1 week after surgery

    Count via medical/pharmacy records

  • Number of tablets of oxycodone prescribed1 month after surgery

    Count via medical/pharmacy records

  • Number of tablets of oxycodone prescribed3 months after surgery

    Count via medical/pharmacy records

  • Average morphine milligram equivalent (MME) of oxycodone tablets prescribed/per participant1 week after surgery

    Mean

  • Average morphine milligram equivalent (MME) of oxycodone tablets prescribed/per participant1 month after surgery

    Mean

  • Average morphine milligram equivalent (MME) of oxycodone tablets prescribed/per participant3 months after surgery

    Mean

  • Number of oxycodone tablets used by study participants1 week after surgery

    Count via survey/interview/visual inspection/photograph

  • Number of oxycodone tablets used by study participants1 month after surgery

    Count via survey/interview/visual inspection/photograph

  • Number of oxycodone tablets used by study participants3 months after surgery

    Count via survey/interview/visual inspection/photograph

  • Average morphine milligram equivalent (MME) of oxycodone tablets used/per participant1 week after surgery

    Mean

  • Average morphine milligram equivalent (MME) of oxycodone tablets used/per participant1 month after surgery

    Mean

  • Average morphine milligram equivalent (MME) of oxycodone tablets used/per participant3 months after surgery

    Mean